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Abstract. Escherichia coli (E. coli) strains are the major cause of urinary tract infections
(UTI) and belong to the large group of extra-intestinal pathogenic E. coli. The purposes of this
study were to determine the antibiotic resistance profile, virulence genes and phylogenetic
background of E. coli isolates from UTI cases. A total of 137 E. coli isolates were obtained
from UTI samples. The antimicrobial susceptibility of confirmed isolates was determined by
disk diffusion method against eight antibiotics. The isolates were examined to determine the
presence and prevalence of selected virulence genes including iucD, sfa/focDE, papEF and
hly. ECOR phylo-groups of isolates were determined by detection of yjaA and chuA genes and
fragment TspE4.C2. The antibiogram results showed that 71% of the isolates were resistant to
cefazolin, 60.42% to co-trimoxazole, 54.16% to nalidixic acid, 36.45% to gentamicin, 29.18% to
ciprofloxacin, 14.58% to cefepime, 6.25% to nitrofurantoin and 0.00% to imipenem. Twenty-
two antibiotic resistance patterns were observed among the isolates. Virulence genotyping
of isolates revealed that 58.39% isolates had at least one of the four virulence genes. The
iucD gene was the most prevalent gene (43.06%). The other genes including sfa/focDE,
papEF and hly genes were detected in 35.76%, 18.97% and 2.18% isolates, respectively. Nine
combination patterns of the virulence genes were detected in isolates. Phylotyping of 137
isolates revealed that the isolates fell into A (45.99%), B1 (13.14%), B2 (19.71%) and D
(21.16%) groups. Phylotyping of multidrug resistant isolates indicated that these isolates are
mostly in A (60.34%) and D (20.38%) groups. In conclusion, the isolates that possessed the
iucD, sfa/focDE, papEF and hly virulence genes mostly belonged to A and B2 groups, whereas
antibiotic resistant isolates were in groups A and D. Escherichia coli strains carrying virulence
factors and antibiotic resistance are distributed in specific phylogenetic background.
INTRODUCTION
Extra-intestinal pathogenic Escherichia
coli (ExPEC) is one of the main agents of
morbidity and mortality in human through
the world (Kudinha et al., 2012). These
agents are responsible for cholecystitis,
traveler’s diarrhoea and other clinical
infections such as neonatal meningitis,
pneumonia, pyelonephritis, cystitis, intestinal
and urinary tract infection (UTI) which is
the most significant disease in ExPEC group
(Anvarinejad et al., 2012; Madappa et al.,
2012).
There are wide diversity of researches
on the virulence factors and genotypic
characteristics of E. coli isolates.
Uropathogenic Escherichia coli (UPEC)
show a variety of virulence factors (VFs).
These VFs participate in colonization,
invasion and, consequently, reduction of
the host immunity responses (Anvarinejad
et al., 2012; Agarwal et al., 2013). The strains
with virulence associated genes consist
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of adhesions, toxins, iron acquisition
systems, biofilms and other virulence factors
(Johnson et al., 2012; Agarwal et al., 2013).
The adhesions such as S and P fimbriae play
the major roles in the pathogenicity of E. coli
strains by colonization stage and overcoming
host immunity (Bahalo et al., 2013). Adhesion
to uroepithelial cells by P fimbriae is an
important step for the beginning and
expansion of UTI (Matiuzzi da Costa et al.,
2008; Bahalo et al., 2013). S fimbriae showed
attachment efficiency to epithelial and
endothelial cells of the lower human urinary
tract (Bien et al., 2012). Studies have shown
papEF and sfa/focDE are essential for
cystitis and/or pyelonephritis (Bahalo et al.,
2013). The iron chelator molecules gain iron
from host cells by aerobactin (iucD) which
is an important factor for growth of extra-
intestinal pathogens of E. coli (Bien et al.,
2012). Haemolysin enzyme is secreted by
uropathogen E. coli species. Haemolysin
(HlyA) causes tissue damages, facilitates
bacterial distribution and participates in
bacterial pathogenesis (Davis et al., 2005;
Johnson et al., 2007).
Escherichia coli strains were assigned
into four major phylogenetic groups: A, B1,
B2 and D and six subgroups A0 and A1 (for
phylogenetic group A), D1 and D2 (for
phylogenetic group D), and B22 and B23 (for
phylogenetic group B2) (Deschamps et al.,
2009; Abdul-Razzaq et al., 2011). Extra-
intestinal pathogenic strains usually fell
into B2 and a lesser extent group D (Abdul-
Razzaq et al., 2011; Platell et al., 2012).
The phylogenetic group B2 isolates mostly
carries more virulence genes than other
isolates (Kawamura–Sato et al., 2010; Abdul-
Razzaq et al., 2011).
Increased and non-controlled anti-
microbial administrations can lead to
acquired resistance in extra-intestinal
infections of E. coli which can lead to
increased healthcare costs through the
world, morbidity and mortality. Therefore,
in order to control the prevalence of
resistant antimicrobial agents, selection of
an antibiotic according to symptoms and
directed by urinalysis is suitable for
uncomplicated cystitis but should be altered
based on culture results for more severe
infections (Sheerin, 2011). The relationship
between phylogenetic background and
antibiotic resistance indicates that group B2
is the more susceptible than A, B1 and D
phylogenetic groups (Kawamura-Sato et al.,
2010). The aim of this study was to determine
the antibiotic resistance profile, virulence
genes and phylogenetic background of E. coli
isolates from patients with UTI in Kerman,
Iran by PCR.
MATERIAL AND METHODS
Bacterial strains
One hundred and thirty seven urinary
samples were obtained from admitted
patients to four different hospitals during
October to December, 2009 in Kerman
province, Iran (south-eastern). The samples
were from 37 males and 100 females (100).
Their age ranged from <15 years old (45), 15
to 30 years old (38), 30 to 45 years old (26)
and 45 to 70 years old (28). The samples were
cultured on MacConkey agar and EMB
(Biolife Laboratories, Milano, Italy). In
order to confirm E. coli isolates, standard
biochemical and bacteriological tests were
used. From each sample one confirmed E.
coli isolate was selected and stored in Luria-
Bertani broth (In vitrogen, Paisley, Scotland)
with 30% sterile glycerol at -70ºC.
PCR and reference strains
Strains were DNA extracted from E. coli
isolates and reference strains by lysis
method. For this study, the presence of the
papEF, sfa/focDE, hly and iucD genes were
determined by PCR method as described
previously (Yamamoto, 2007) and phylo-
genetic groups (A, B1, B2, and D) of E. coli
isolates were carried out by triplex PCR
by Clermont et al. (2000). Escherichia coli
reference strains ECOR62 (chuA+, yjaA+ and
Tspe4.C2+), 28C (hly+), J96 (sfa/focDE+,
papEF+) and A30 (iucD+) were used as
positive controls. Escherichia coli strain
MG1655 was used as a negative control. All
the reference strains were from Microbiology
Department of Ecole Nationale Vétérinaire
Toulouse. The primers used for detecting
sequences encoding virulence genes and
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phylogenetic groups are described in
Table 1.
Antimicrobial susceptibility testing
The antimicrobial susceptibility of E. coli
isolates were determined by disk diffusion
method following the Clinical Laboratory
Standards Institute (CLSI) guidelines using
commercial antimicrobial disks (Mast. Co.,
UK). The antibiotic disks used in this study
were cefazolin (30 µg), ciprofloxacin (5 µg),
co-trimoxazole (1.25/23.75 µg), nitrofurantoin
(300 µg), gentamicin (10 µg), imipenem (10
µg), cefepime (30 µg) and nalidixic acid (30
µg). Escherichia coli ATCC 25922 was used
as a quality control strain. In literal terms,
multidrug resistant (MDR) means resistant
to more than one antimicrobial agent in vitro
(Magiorakos et al., 2012).
RESULTS
PCR assays revealed that 137 isolates
belonged to A 45.99% (63 isolates), B1 13.14%
(18), B2 19.71% (27) and D 21.16% (29)
phylogenetic groups. Phylotyping of isolates
indicated that the isolates could be
categorized into six subgroups: A0 (33.59%),
A1 (12.41%), B22 (1.45%), B23 (18.25%), D1
(6.56%), and D2 (14.60%). Subgroups A0 and
B23 were the most prevalent among the
examined isolates.
From the disk diffusion assay, the
current study found that 71% of the E. coli
UTI isolates were resistant to cefazolin.
Different percentages of antibiotic resistance
were recorded against co-trimoxazole
(60.42%), nalidixic acid (54.16%), gentamicin
(36.45%), ciprofloxacin (29.18%), cefepime
(14.58%), and nitrofurantoin (6.25%).
However, none of the isolates were resistant
to imipenem. One isolate was sensitive to
ciprofloxacin, cefepime, gentamicin,
nitrofurantoin, and co-trimoxazole, while
intermediate to cefazolin and nalidixic acid.
Twenty two antibiotic resistance patterns
were detected in relation to phylogenetic
groups (Table 2). Phylotyping of antibiotic
resistant isolates demonstrated that these
isolates mostly belonged to A (41.28%) and D
(19.03%) groups (Table 2). Phylogenetic
background of quinolone-resistant (resistant
to ciprofloxacin and nalidixic acid patterns)
and MDR isolates including all of the
antibiotic resistant patterns except cefazolin,
nalidixic acid and co-trimoxazole patterns
indicated that these isolates were mostly in
groups A (60.34%) and D (20.38%).
Among antibiotic resistant patterns,
cefazolin+nalidixic-acid+co-trimoxazole
and cefazolin+co-trimoxazole were the most
prevalent patterns, which had at least one of
the iucD, sfa/focDE, papEF and hly genes
(Table 3).
Virulence genotyping of isolates
indicated that 80 (58.39%) isolates had at
least one of virulence-associated genes. The
aerobactin encoding genetic marker (iucD)
was the most prevalent gene (43.06%) in the
isolates, while 36 (26.28%) isolates were
positive for this gene in combination with
other genes, and 23 (16.78%) isolates had
just the iucD gene (Table 4). Phylotyping of
59 isolates possessed the genetic marker
iucD showed that the isolates distributed
in four phylogenetic groups including A
(31 isolates), B1 (6), B2 (12) and D (10)
phylogenetic groups.
The P and S fimbriae coding genes were
detected in 26 (18.97%) and 49 (35.76%)
isolates of UTI isolates, respectively. PCR
assays revealed that 31.38% isolates
possessed sfa/focDE gene in combination
with other genes and 6 (4.37%) isolates just
exhibited the sfa/focDE gene. Among the
isolates positive for papEF gene, 6 (4.37%)
of the isolates possessed papEF gene
exclusively, whereas 14.59% of isolates
showed the genetic marker papEF in the
present of other genes (Table 4). Twenty
six isolates were positive for papEF gene,
which segregated in A (6 isolates), B1 (2),
B2 (14) and D (4) phylogenetic groups. Also
49 isolates were positive for sfa/focDE gene
that fell into A (19 isolates), B1 (3), B2 (19)
and D (8) phylogenetic groups. The positive
isolates for virulence genes were distributed
in six phylogenetic subgroups (Table 5).
The genetic marker hemolysin (hly) was
present in 2.18% isolates in combination
with other genes (Table 4) that fell into A
(1 isolate) and B2 (2) phylogenetic groups.
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Table 2. Antibiotic resistance patterns in relation to phylogenetic background
CIP ciprofloxacin, CPM cefepime, CZ cefazolin, GM gentamicin, NA nalidixic acid, NI nitrofurantoin,
TS co-trimoxazole
Antibiotic resistance patterns
A B1 B2 D
Total
Phylogenetic group
7
2
1
7
1
4
1
8
–
1
3
2
1
1
2
3
2
4
–
–
3
4
57
6
–
–
–
–
–
–
4
2
–
1
–
–
2
–
–
–
–
2
–
1
–
18
5
–
–
4
7
–
–
6
2
–
2
–
–
–
–
–
–
2
2
–
1
–
31
3
–
–
4
5
3
2
2
–
–
–
2
–
–
–
–
2
2
–
4
1
–
30
21
2
1
15
13
7
3
20
4
1
6
4
1
3
2
3
4
8
4
4
6
4
136
CZ
TS
NI
CZ, TS
CZ,GM
CZ, NA
NA,TS
CZ, NA, TS
CZ,GM, TS
CIP, CZ, NA
CIP, CZ, NA,TS
CZ,GM, NA,TS
CIP, CZ, GM, TS
CIP, CZ, GM, NA
CPM, CZ, GM, NI
CPM, CZ, GM, TS
CIP, CZ, NA, NI, TS
CIP, CZ, GM, NA, TS
CPM, CZ, GM, NA, TS
CIP, CPM, CZ, GM, NA
CIP, CPM, CZ,GM, NA,TS
CIP, CPM, CZ, GM, NA, NI, TS
Total
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Table 3. Antibiotic resistance patterns in relation to virulence genes
CIP ciprofloxacin, CPM cefepime, CZ cefazolin, GM gentamicin, NA nalidixic acid, NI nitrofurantoin,
TS co-trimoxazole
Antibiotic resistance patterns
iucD sfa/focDE papEF hly
Total
Virulence genes
8
–
–
8
1
1
–
10
–
1
9
3
–
1
1
–
–
3
1
–
9
–
56
3
–
–
8
8
1
1
8
1
–
6
3
–
–
1
–
–
–
–
–
6
–
46
6
–
–
4
8
1
1
4
–
–
–
–
–
–
–
–
–
–
–
–
–
–
24
1
–
–
1
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
2
18
–
–
21
17
3
2
22
1
1
15
6
-
1
2
–
–
3
1
–
15
–
128
CZ
TS
NI
CZ, TS
CZ,GM
CZ, NA
NA,TS
CZ, NA, TS
CZ,GM, TS
CIP, CZ, NA
CIP, CZ, NA,TS
CZ,GM, NA,TS
CIP, CZ, GM, TS
CIP, CZ, GM, NA
CPM, CZ, GM, NI
CPM, CZ, GM, TS
CIP, CZ, NA, NI, TS
CIP, CZ, GM, NA, TS
CPM, CZ, GM, NA, TS
CIP, CPM, CZ, GM, NA
CIP, CPM, CZ,GM, NA,TS
CIP, CPM, CZ, GM, NA, NI, TS
Total
Table 4. Virulence genes and their combination patterns detected in 137 E. coli isolates from UTI
Combination patterns
                          Gene Total No
sfa/focDE papEF iucD hly (%)
sfa/focDE + – – – 06 (4.37%)
papEF – + – – 06 (4.37%)
iucD – – + – 23 (16.78%)
iucD/sfa + – + – 24 (17.51%)
papEF/sfa + + – – 10 (7.29%)
papEF/iucD – + + – 01 (0.72%)
iucD/hly – – + + 01 (0.72%)
papEF/iucD/sfa + + + – 08 (5.83%)
papEF/iucD/sfa/hly + + + + 01 (0.72%)
Negative – – – – 57 (41.60%)
Total No (%) 49 (35.76%) 26 (18.97%) 59 (43.06%) 3 (2.18%) 137 (100%)
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According to the results, nine patterns of
gene combination were detected. Among
137 E. coli isolates, iucD+sfa/focDE
(17.51%) and papEF+sfa/focDE (7.29%)
patterns were the most prevalent in the
isolates, respectively (Table 4).
DISCUSSION
This study addressed the important roles of
virulence genes in E. coli UTI. The virulence
associated genes play important roles in
development of extra-intestinal E. coli
infections (Wang et al., 2002). These isolates
can be defined into four major phylogenetic
groups: A, B1, B2, and D. In E. coli extra-
intestinal infections, B2 group was more
predominant than three other phylogenetic
groups (Rijavec et al., 2008). The relationship
between phylogenetic groups and resistance
has shown that group B2 strains were more
susceptible to antibiotics than were groups
A, B1 and D strains. On the other hand, many
studies reported that quinolone-resistant and
fluoroquinolone-resistant strains fell into
specific phylogenetic background, such as
A and D (Moreno et al., 2006; Kawamura-
Sato et al., 2010).
In the current study, siderophore
encoding gene (iucD) was found to be the
most prevalent isolate (43.8%), compared
to 25.9% reported by Tiba et al. (2008) and
46% reported by Marrs et al. (2002), while
other studies reported 91% and 59% (Piatti
et al., 2008; Rijavec et al., 2008). Aerobactin
siderophore systems would be necessary to
obtain iron from iron chelator molecules
(Ejrnæs, 2011).
In the present study, fimbrial genes were
examined in the isolates. These genes involve
in potential binding to epithelial cells in
lower human urinary tract. The results
showed that more isolates harboured the
sfa/focDE (36.5%) gene compared to the
papEF (17.5%) gene. In the other parts of the
world, some researches have determined
the significance of these virulence genes in
pathogenicity. Tiba et al. (2008) showed that
27.8% and 32.7% of isolates possessed sfa/
focDE and papEF genes, respectively. In
Brazil, prevalence of sfa/focDE gene in
combination with papEF gene was 83.3%
(Santo et al., 2006). In a study on Iran, 27.15
and 14.6% of E. coli isolates possessed pap
and sfa genes (Farshad et al., 2009).
This study demonstrated that hemolysin
encoding sequence (hly) was present in a
small percentage (2.2%) of isolates. It is
believed that hly is more common amongst
invasive uropathogenic strains than healthy
fecal isolates (Katouli & Vollmerhausen,
2010). In India, 4.7% of E. coli isolates
associated with acute cystitis in women
were positive for hemolysin genetic marker
(Agarwal et al., 2013), whereas Yamamato
(2007) showed most frequencies of
isolates (41.2%) possessed hly gene.
PCR analyses of phylotyping deter-
mination showed that E. coli isolates mostly
fell into group A, followed by B2 and D. The
finding of the present study is in agreement
with study by Piatti et al. (2008), which
reported A and B1 phylogenetic groups
were the most prevalent in the isolates,
respectively. In contrast, several previous
investigations have indicated that most of the
isolates belonged to B2 followed by D and B1
groups (Kawamura-Sato et al., 2010; Choi et
al., 2012).
ExPEC strains, which cause UTI,
commonly belong to the groups B2 or D,
whereas strains of the B2 and D groups
involved more virulence-associated genes
Table 5. Virulence genes in UTI isolates in relation to group/subgroups phylogenetic
Gene A0 A1 B1 B22 B23 D1 D2 Total N (%)
PapEF 03 (11.54) 03 (11.54) 02 (7.70)0 – 14 (53.84) – 04 (15.38) 26 (100.00)
iucD 21 (35.60) 10 (16.95) 06 (10.17) – 12 (20.34) 1 (1.69) 09 (15.25) 59 (100.00)
sfa/focDE 16 (32.66) 03 (6.12)0 03 (6.12)0 – 19 (38.77) – 08 (16.33) 49 (100.00)
hly – 01 (33.33) – 2 (66.67) – – – 3 (100.00)
Total N (%) 40 (29.20) 17 (12.41) 11 (8.03) 2 (1.46)0 45 (32.85) 1 (0.72) 21 (15.33) 137 (100.00)
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than strains of the A and B1 groups
(Nowrouzian et al., 2006). Grude et al. (2007)
surveyed E. coli isolates from Norwegian
and Russian females with significant
bacteruria who presented with clinical signs
of UTI; Russian isolates fell into more often
to A phylogenetic group and possessed fewer
virulence genes than did Norwegian isolates,
whereas groups B2 and D were significant
among the Norwegian isolates and were
higher in number of virulence genes than
did Russian isolates (Grude et al., 2007).
In the present study, most of the isolates
were resistant to cefazolin, co-trimoxazole
and nalidixic acid. Farshad et al. (2009)
showed that highest antibiotic resistances
were towards imipenem, nitrofurantuin
and ciprofloxacin, while nalidixic acid
and gentamycin were more sensitive. In
accordance, in a study in Brazil, co-
trimoxazole, nalidixic acid, gentamycin,
ciprofloxacin and cephalothin were the most
resistant in the isolates (Oliveria et al., 2011).
Several previous investigations have
demonstrated that quinolone-resistant and
MDR are associated with a shift towards
non-B2 phylogenetic groups (Johnson et
al., 2005; Rijavec et al., 2008). Based on the
results nitrofurantoin, ciprofloxacin, co-
trimoxazole and nalidixic acid belonged to A
and D groups whereas E. coli isolates that
were sensitive to imipenem fell into B2
phylogenetic group. Moreover, Moreno et al.
(2006) found that isolates susceptible to
quinolone, fluoroquinolone and trimethoprim/
sulfamethoxazole were significantly
associated with phylogenetic group B2,
whereas resistant isolates exhibited shifts to
A and D groups (Moreno et al. 2006).
In conclusion, the E. coli strains were
segregated into different phylogenetic
groups, and the B2 phylogenetic group
represented the majority of strains involved
in different extra-intestinal infections. The
current findings indicated that the virulence
associated genes were mostly distributed in
A and B2 groups, while antibiotic resistant
strains were mainly in A and D phylogenetic
groups. B2 phylogenetic group strains were
less prone to be resistant to antibiotics than
non-B2 strains. Therefore, although E. coli
strains carried virulence factors and acquired
the resistance by mutation, which were
distributed in some specific phylogenetic
background, the relationship was complex.
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